Contact
searchSearch
HMP Global

Gastroenterology

Featured

Expert Insights
What's Ahead for MASLD and MASH?
10/26/2026
Robert Fontana, MD; Manal Abdelmalek, MD; Juan Pablo Arab, MD
The expert roundtable on MASH and MASLD wraps up as Drs Fontana, Abdelmalek, and Arab consider advances in progress and encourage gastroenterologists to make use of the tools available today to risk assess, treat, and monitor their patients...
The expert roundtable on MASH and MASLD wraps up as Drs Fontana, Abdelmalek, and Arab consider advances in progress and encourage gastroenterologists to make use of the tools available today to risk assess, treat, and monitor their patients...
The expert roundtable on MASH...
10/26/2026
Gastroenterology
Expert Insights
Emerging Therapies and Bariatric Treatment for MASLD and MASH
10/26/2026
Robert Fontana, MD; Manal Abdelmalek, MD; Juan Pablo Arab, MD
Drs Fontana, Abdelmalek, and Arab discuss new therapeutic options now being developed, as well as the continued role of bariatic therapies, including endobariatics as well as surgery, for the treatment of obese patients with MASLD or MASH.
Drs Fontana, Abdelmalek, and Arab discuss new therapeutic options now being developed, as well as the continued role of bariatic therapies, including endobariatics as well as surgery, for the treatment of obese patients with MASLD or MASH.
Drs Fontana, Abdelmalek, and...
10/26/2026
Gastroenterology
Expert Insights
Diet and Alternative Therapies in MASLD and MASH
10/26/2026
Robert Fontana, MD; Manal Abdelmalek, MD; Juan Pablo Arab, MD
Diet remains a mainstay of treatment for MASLD and MASH, according to our roundtable experts, who further explore alternative therapies including vitamin E and follow-up monitoring of patients to assess progress.
Diet remains a mainstay of treatment for MASLD and MASH, according to our roundtable experts, who further explore alternative therapies including vitamin E and follow-up monitoring of patients to assess progress.
Diet remains a mainstay of...
10/26/2026
Gastroenterology
Expert Insights
Diet and Alternative Therapies in MASLD and MASH
10/26/2026
Robert Fontana, MD; Manal Abdelmalek, MD; Juan Pablo Arab, MD
Drs Fontana, Arab, and Abdelmalek continue their discussion on the treatment of MASLD and MASH, discussing the importance of dietary therapy and the possible addition of vitamin E for some patients, as well as getting follow-up imaging to...
Drs Fontana, Arab, and Abdelmalek continue their discussion on the treatment of MASLD and MASH, discussing the importance of dietary therapy and the possible addition of vitamin E for some patients, as well as getting follow-up imaging to...
Drs Fontana, Arab, and...
10/26/2026
Gastroenterology
Expert Insights
Treating MASLD and MASH
10/26/2026
Robert Fontana, MD; Manal Abdelmalek, MD; Juan Pablo Arab, MD
Our expert roundtable on MASLD and MASH takes a dive into the treatments now approved for MASLD and MASH and how to approach shared decision-making with patients when choosing therapeutics.
Our expert roundtable on MASLD and MASH takes a dive into the treatments now approved for MASLD and MASH and how to approach shared decision-making with patients when choosing therapeutics.
Our expert roundtable on MASLD...
10/26/2026
Gastroenterology
Brian Lacy
Conference Coverage
Brian Lacy, MD, on Bloating and Distension
10/26/2026
Brian E. Lacy, PhD, MD
Dr Lacy discusses how to discern between bloating and distension, identifies the key contributors to these conditions, and goes through the treatment options he presented at the ACG Scientific Meeting.
Dr Lacy discusses how to discern between bloating and distension, identifies the key contributors to these conditions, and goes through the treatment options he presented at the ACG Scientific Meeting.
Dr Lacy discusses how to discern...
10/26/2026
Gastroenterology
Rena Yadlapati
Conference Coverage
Rena Yadlapati, MD, on Differentiating Acid vs Nonacid Reflux
10/26/2026
Rena Yadlapati, MD
Dr Yadlapati review her presentation from the ACG Scientific Meeting on diagnosis of acid reflux vs nonacid reflux and how to approach the treatment and monitoring of these conditions.
Dr Yadlapati review her presentation from the ACG Scientific Meeting on diagnosis of acid reflux vs nonacid reflux and how to approach the treatment and monitoring of these conditions.
Dr Yadlapati review her...
10/26/2026
Gastroenterology
Lin Chang
Conference Coverage
Lin Chang, MD, on What's New in Rome V
10/20/2026
Lin Chang, MD
Dr Chang reviews important changes in the Rome V diagnostic criteria for disorders of gut-brain interaction, which she detailed during her lecture at the American College of Gastroenterology Scientific Meeting in Nashville, October 12-14.
Dr Chang reviews important changes in the Rome V diagnostic criteria for disorders of gut-brain interaction, which she detailed during her lecture at the American College of Gastroenterology Scientific Meeting in Nashville, October 12-14.
Dr Chang reviews important...
10/20/2026
Gastroenterology
FDA Approval
FDA Grants Accelerated Approval to Dostarlimab for MSI-H/dMMR Rectal Cancer
10/20/2026
Rebecca Mashaw
Of 154 treated patients, 110 (71%) were treated with dostarlimab alone, did not receive any additional form of treatment, and did not experience disease progression of Stage II/III locally advanced rectal cancer.
Of 154 treated patients, 110 (71%) were treated with dostarlimab alone, did not receive any additional form of treatment, and did not experience disease progression of Stage II/III locally advanced rectal cancer.
Of 154 treated patients, 110...
10/20/2026
Gastroenterology
Expert Insights
Diagnosis and Monitoring in MASLD/MASH
10/16/2026
Robert Fontana, MD; Manal Abdelmalek, MD; Juan Pablo Arab, MD
Drs Fontana, Abdelmalek, and Arab review potential confounders for liver stiffness tests—from food or alcohol to even a cup of coffee—and the best methods to use for both diagnosis and continued monitoring for patients with MASLD or MASH,...
Drs Fontana, Abdelmalek, and Arab review potential confounders for liver stiffness tests—from food or alcohol to even a cup of coffee—and the best methods to use for both diagnosis and continued monitoring for patients with MASLD or MASH,...
Drs Fontana, Abdelmalek, and...
10/16/2026
Gastroenterology
Expert Insights
Fibrosis and Steatosis in MASLD/MASH
10/16/2026
Robert Fontana, MD; Juan Pablo Arab, MD; Manal Abdelmalek, MD
Our expert panel continues this series on MASLD and MASH, discussing how best to diagnose and quantify fibrosis through FIB-4, VCTE, MRE and other blood and imaging tests.
Our expert panel continues this series on MASLD and MASH, discussing how best to diagnose and quantify fibrosis through FIB-4, VCTE, MRE and other blood and imaging tests.
Our expert panel continues this...
10/16/2026
Gastroenterology

News

News
Vonoprazan-Tetracycline Dual Therapy Shows Noninferior H. pylori Eradication
09/08/2026
Jessica Garlewicz
A 14-day vonoprazan-tetracycline dual regimen was noninferior to bismuth quadruple therapy as rescue treatment for Helicobacter pylori infection and was associated with fewer adverse events and better adherence, according to results from a...
A 14-day vonoprazan-tetracycline dual regimen was noninferior to bismuth quadruple therapy as rescue treatment for Helicobacter pylori infection and was associated with fewer adverse events and better adherence, according to results from a...
A 14-day vonoprazan-tetracycline...
09/08/2026
Gastroenterology
News
Updated Guideline Recommends Selective Antibiotic Use for Outpatient Diverticulitis Management
09/08/2026
Jessica Garlewicz
A new evidence-based guideline outlines practical recommendations for the outpatient management of colonic diverticulitis, emphasizing confirmation of diagnosis with computed tomography (CT), selective use of antibiotics, and lifestyle...
A new evidence-based guideline outlines practical recommendations for the outpatient management of colonic diverticulitis, emphasizing confirmation of diagnosis with computed tomography (CT), selective use of antibiotics, and lifestyle...
A new evidence-based guideline...
09/08/2026
Gastroenterology
News
Low-Dose Gluten Exposure Triggers Immune Activation in Treated Celiac Disease Despite Minimal Symptoms
09/08/2026
Jessica Garlewicz
Very small amounts of gluten triggered measurable immune activation in adults with treated celiac disease, even when symptoms were absent, according to a randomized, placebo-controlled dose-response trial. The findings suggest that immune...
Very small amounts of gluten triggered measurable immune activation in adults with treated celiac disease, even when symptoms were absent, according to a randomized, placebo-controlled dose-response trial. The findings suggest that immune...
Very small amounts of gluten...
09/08/2026
Gastroenterology
News
Combined H. pylori and FIT Screening Found Cost-Effective for Long-Term Cancer Prevention
09/08/2026
Jessica Garlewicz
Adding one-time Helicobacter pylori stool antigen testing to biennial fecal immunochemical test (FIT) screening may improve long-term health outcomes while remaining economically favorable, according to a cost-effectiveness analysis based on...
Adding one-time Helicobacter pylori stool antigen testing to biennial fecal immunochemical test (FIT) screening may improve long-term health outcomes while remaining economically favorable, according to a cost-effectiveness analysis based on...
Adding one-time Helicobacter...
09/08/2026
Gastroenterology
News
Celiac Disease Associated With Nearly 3-Fold Higher Risk of Solid Organ Transplantation
09/08/2026
Jessica Garlewicz
Patients with celiac disease (CeD) may face a substantially increased risk of solid organ transplantation, particularly liver transplantation, according to a nationwide population-based cohort study from Sweden. Although celiac disease has...
Patients with celiac disease (CeD) may face a substantially increased risk of solid organ transplantation, particularly liver transplantation, according to a nationwide population-based cohort study from Sweden. Although celiac disease has...
Patients with celiac disease...
09/08/2026
Gastroenterology
News
Refined Fibrosis Screening Criteria Reduce Eligible Population, Improve Detection of Advanced Liver Disease
09/08/2026
Jessica Garlewicz
A refined fibrosis screening strategy substantially reduced the number of adults identified for screening while increasing the likelihood of detecting clinically significant liver fibrosis, according to an analysis of US population data with...
A refined fibrosis screening strategy substantially reduced the number of adults identified for screening while increasing the likelihood of detecting clinically significant liver fibrosis, according to an analysis of US population data with...
A refined fibrosis screening...
09/08/2026
Gastroenterology
News
Menopause May Help Explain Age-Related Fibrosis Risk in Women With MASLD
09/08/2026
Jessica Garlewicz
Menopause may partially mediate the association between aging and advanced fibrosis in women with metabolic dysfunction-associated steatotic liver disease (MASLD), according to findings from a causal mediation analysis of the Harris County...
Menopause may partially mediate the association between aging and advanced fibrosis in women with metabolic dysfunction-associated steatotic liver disease (MASLD), according to findings from a causal mediation analysis of the Harris County...
Menopause may partially mediate...
09/08/2026
Gastroenterology
FDA Approval
FDA Approves SimpleScreen CRC Blood Test for U.S. Colorectal Cancer Screening
07/28/2026
Rebecca Mashaw
FDA approval was based on results of PREEMPT CRC, a prospective clinical validation study that enrolled more than 48,000 asymptomatic, average-risk adults between the ages of 45 and 85.
FDA approval was based on results of PREEMPT CRC, a prospective clinical validation study that enrolled more than 48,000 asymptomatic, average-risk adults between the ages of 45 and 85.
FDA approval was based on...
07/28/2026
Gastroenterology
Research Highlights
GLP-1 RAs Linked to Lower Risk of Hepatic Complications in MASLD and T2D
06/11/2026
Jessica Garlewicz
A real-world cohort study found that patients with MASLD and type 2 diabetes who were not using GLP-1 RAs had a signficantly higher rate of hepatic complications compared to patients receiving GLP-1 therapy.
A real-world cohort study found that patients with MASLD and type 2 diabetes who were not using GLP-1 RAs had a signficantly higher rate of hepatic complications compared to patients receiving GLP-1 therapy.
A real-world cohort study found...
06/11/2026
Gastroenterology
Research Insights
IBS-C Microbiome Signatures Offer Insights Into Parkinson’s-Related Constipation
06/09/2026
Rebecca Mashaw
New research highlights important similarities and differences between IBS-C and Parkinson’s disease–associated constipation.
New research highlights important similarities and differences between IBS-C and Parkinson’s disease–associated constipation.
New research highlights...
06/09/2026
Gastroenterology

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use